Hormone replacement therapy and reduced cognitive decline in older women: the Cache County Study.
about
Role of androgens, progestins and tibolone in the treatment of menopausal symptoms: a review of the clinical evidencePopulation-based neuropathological studies of dementia: design, methods and areas of investigation--a systematic reviewOestrogen has neuroprotective effects and may reduce the risk of Alzheimer's disease.Promoting successful cognitive aging: a comprehensive review.The Cache County Study on Memory in Aging: factors affecting risk of Alzheimer's disease and its progression after onsetII. Cognitive performance of middle-aged female rats is influenced by capacity to metabolize progesterone in the prefrontal cortex and hippocampus.Prevention of Alzheimer's disease: where we stand.Transcriptome meta-analysis reveals a central role for sex steroids in the degeneration of hippocampal neurons in Alzheimer's diseaseSalivary sex hormone measurement in a national, population-based study of older adultsAntioxidants as treatment for neurodegenerative disorders.Interactive effects of age and estrogen on cortical neurons: implications for cognitive aging.Benefits and risks of sex hormone replacement in postmenopausal women.Role of progestins with partial antiandrogenic effects.Postmenopausal hormone therapy, timing of initiation, APOE and cognitive decline.Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbersCognitive functioning and aging in women.APOE genotype predicts depression in women with Alzheimer's disease: a retrospective studyCognitive changes after menopause: influence of estrogenDementia prevention: methodological explanations for inconsistent results.Protective actions of sex steroid hormones in Alzheimer's disease.Frontiers proposal. National Institute on Aging "bench to bedside: estrogen as a case study".Postmenopausal hormone therapy is not associated with risk of all-cause dementia and Alzheimer's disease.A multi-center, randomized, double blind placebo-controlled trial of estrogens to prevent Alzheimer's disease and loss of memory in women: design and baseline characteristics.Continuously delivered ovarian steroids do not alter dendritic spine density or morphology in macaque dorsolateral prefrontal cortical neuronsIndividualizing hormone therapy to minimize risk: accurate assessment of risks and benefits.Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.Effects of synaptic plasticity regulated by 17beta-estradiol on learning and memory in rats with Alzheimer's disease.Hormone use and cognitive performance in women of advanced age.Characterization of the role of the antioxidant proteins metallothioneins 1 and 2 in an animal model of Alzheimer's disease.Frontal cerebral blood flow changes after hormone replacement therapy in depressed postmenopausal women.Children of Alzheimer patients: an overview.Antipsychotika und Hyperprolaktinämie: Pathophysiologie, klinische Bedeutung, Abklärung und Therapie
P2860
Q24647700-D874D9B1-21A8-4C28-B573-4D9B802D47EAQ25257388-ED8C8DA9-E652-4177-8540-E9D2D15CEE13Q30712450-17E3CCC2-06A8-4441-9D2E-27ECCA6D03F3Q33544151-170C8A89-1963-4017-8619-E53F67275DBCQ33873941-EE5222BA-0BA3-47A1-8D85-1A083F05C713Q34570708-77070EFD-737A-49FA-A9F9-BA7BAB7A51DBQ34778089-57CAFFF2-5B3F-432C-B5A6-78C189E67BD1Q34784966-EDA522D7-E0F2-4D1F-86C6-67C6883CB59BQ34940600-B563CA41-FBF5-4153-B6BA-5979C8E5A03BQ34974866-C322F9A7-3596-46F8-A9FF-2CB8AED49AABQ35194607-2ABCFDAE-A571-4476-8FBE-484321123BDEQ35910115-3D7CCDAB-9759-4DE3-9BBC-D9560DB2A303Q36019567-A0D9E962-AA5C-4869-BA19-932034EA77D0Q36355137-D1B16B91-5FEE-4F12-8398-B2FA27C10858Q36799584-EE0C7376-F3D2-40AD-9D19-67E18B71B45AQ36858541-5D5B41EC-DA3A-4984-9BC8-A76830B14897Q36974143-E24337AB-FCE9-439F-9D60-FA6677D1A79AQ37088621-D3966153-7637-4223-B433-6225E61443A5Q37263684-73F3678A-DD9C-4D1C-A56B-43856FFABE26Q37309638-9DADCB24-C2CB-4AFD-8BDF-1E5D2CDB9259Q37324566-98D309B3-6C53-4C93-96E3-7FC59CA7D614Q37416371-A4B164BF-3C33-42A8-9C81-184D058F3801Q37448850-3C7A8A38-12A1-4BB8-8174-6E891FE83816Q37642394-0A0E1764-B71F-4C6D-8D8F-CA7DB1CAF185Q37905818-0B4E722D-3B8E-4B06-84A0-FEBD0B16316DQ40404638-08EF2D50-1FF3-45B7-9F98-48C5B14AECF3Q41442478-8B55DF51-A8C5-4EA3-9F6E-E8DC7C009B0BQ46155906-0CEDAB1B-85DE-47DF-AF04-0FAE5038E670Q48449769-D63F4FAB-71BF-4D5B-9B7B-FFA03B02F35AQ48494441-7F064B1E-AA53-40CF-988D-AB9DDE634847Q53273836-FD21A2F8-96F0-4531-9DE5-A86338E4B92DQ58896851-083E95D7-238E-4FCF-93E4-2A102445A40F
P2860
Hormone replacement therapy and reduced cognitive decline in older women: the Cache County Study.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Hormone replacement therapy an ...... women: the Cache County Study.
@en
Hormone replacement therapy an ...... women: the Cache County Study.
@nl
type
label
Hormone replacement therapy an ...... women: the Cache County Study.
@en
Hormone replacement therapy an ...... women: the Cache County Study.
@nl
prefLabel
Hormone replacement therapy an ...... women: the Cache County Study.
@en
Hormone replacement therapy an ...... women: the Cache County Study.
@nl
P2093
P356
P1433
P1476
Hormone replacement therapy an ...... women: the Cache County Study.
@en
P2093
B L Plassman
Cache County Study Group
D C Steffens
J C Breitner
J T Tschanz
K A Welsh-Bohmer
L A Bastian
M C Carlson
P304
P356
10.1212/WNL.57.12.2210
P407
P577
2001-12-01T00:00:00Z